Is AZN or STX cheaper?

On trailing earnings, AZN is cheaper: AZN trades at a 26.92 P/E and STX at 88.33.

Which has grown faster, AZN or STX?

Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus STX at 1.57%.

Does AZN or STX pay a bigger dividend?

AZN yields 1.79% and STX yields 0.31% based on trailing dividends and the latest price.

Is AZN or STX more profitable?

STX runs the higher net margin — AZN at 17.19% versus STX at 21.60%.

Which has been the better investment, AZN or STX?

Over the past 10-year, STX delivered the higher annualized total return — AZN at 15.77% versus STX at 50.80%. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Seagate Technology Holdings plc (STX)

AZN leads on 10 of 17 compared metrics.

A side-by-side comparison of AstraZeneca PLC and Seagate Technology Holdings plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Seagate Technology Holdings plc

$208.77B

$931.04Technology

Total return — AZN vs STX

growth of $100 · last 24y

AZN +400.0%STX +7996.0%STX compounded faster

Log scale — wide-divergence pair

AZN STX

AZN vs STX: by the numbers

•AZN is the larger company ($277.22B vs $208.77B market cap).
•AZN trades at the lower earnings multiple (26.92 vs 88.33 P/E).
•STX converts more revenue to profit (21.60% vs 17.19% net margin).
•AZN grew revenue faster over the past five years (16.99% vs 1.57% CAGR).
•AZN pays the higher dividend yield (1.79% vs 0.31%).

Which is better, AZN or STX?

Metric tally: AZN 10 · STX 7

It depends on what you're optimizing for:

ValueAZN(lower P/E)

GrowthAZN(faster 5Y revenue CAGR)

IncomeAZN(higher dividend yield)

QualitySTX(higher ROIC)

Metrics side by side

Valuation

Metric	AZN	STX
P/E ratio	26.92●	88.33
Forward P/E	15.33●	34.14
P/S ratio	4.62●	19.36
P/B ratio	5.90●	194.71
PEG ratio	0.14	0.06●
EV / EBITDA	14.92●	65.31
FCF yield	2.89%●	1.23%

Profitability

Metric	AZN	STX
Gross margin	81.68%●	41.54%
Operating margin	23.69%	28.33%●
Net margin	17.19%	21.60%●
ROE	21.95%	217.17%●
ROIC	13.03%	34.14%●

Dividends

Metric	AZN	STX
Dividend yield	1.79%●	0.31%
Payout ratio	48.48%	42.14%

Growth (annualized)

Metric	AZN	STX
Revenue CAGR (5Y)	16.99%●	1.57%
EPS CAGR (5Y)	22.02%●	-0.47%
FCF CAGR (5Y)	15.68%	20.22%●
Total return CAGR (5Y)	11.03%	61.98%●

Frequently asked

Which is better, AZN or STX?: It depends on your goal. value: AZN (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: STX (higher ROIC). Across all compared metrics, AZN leads 10 to 7.
Is AZN or STX cheaper?: On trailing earnings, AZN is cheaper: AZN trades at a 26.92 P/E and STX at 88.33.
Which has grown faster, AZN or STX?: Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus STX at 1.57%.
Does AZN or STX pay a bigger dividend?: AZN yields 1.79% and STX yields 0.31% based on trailing dividends and the latest price.
Is AZN or STX more profitable?: STX runs the higher net margin — AZN at 17.19% versus STX at 21.60%.
Which has been the better investment, AZN or STX?: Over the past 10-year, STX delivered the higher annualized total return — AZN at 15.77% versus STX at 50.80%. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full STX analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Seagate Technology P/E ratio AstraZeneca dividend yield Seagate Technology dividend yield AstraZeneca ROE Seagate Technology ROE AstraZeneca operating margin Seagate Technology operating margin AstraZeneca revenue growth Seagate Technology revenue growth AstraZeneca free cash flow Seagate Technology free cash flow

AstraZeneca & Seagate Technology appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.